866-997-4948(US-Canada Toll Free)

Bio-Rad Laboratories, Inc. (BIO) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 48 Pages


Bio-Rad Laboratories, Inc. (Bio-Rad) is engaged in the development and manufacture of specialty chemicals for use in biochemical, pharmaceutical and other life science research applications. The company supplies a wide range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components to the life science research, healthcare, analytical chemistry and other markets. Through its global network of operations, the company serves more than 100,000 research and industry customers around the world. The company operates in more than 35 countries in North America, Europe, Asia, Middle East and Africa. Bio-Rad is headquartered in California, the US.

The company\'s strategy is to grow by acquisitions and investments. It focuses on research and development in order to achieve product development. In line with its strategy in October 2011, Bio-Rad purchased QuantaLife, Inc. for $162m.

This report is a source for data, analysis and actionable intelligence on the Bio-Rad Laboratories, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5

Bio-Rad Laboratories, Inc. - Business Description 6

Key Facts 7
Bio-Rad Laboratories, Inc. - Major Products and Services 8
Bio-Rad Laboratories, Inc. Pipeline Products by Equipment Type 9
Bio-Rad Laboratories, Inc. Pipeline Products by Development Stage 11
Bio-Rad Laboratories, Inc. Pipeline Products by Therapy Area 13
BioPlex 2200 - Cardiac Disease 15
BioPlex 2200 - Cardiac Disease Product Status 15
BioPlex 2200 - Cardiac Disease Product Description 15
BioPlex 2200 - Cardiac Disease Product Patent Details 15
BioPlex 2200 - Celiac Disease IgA tTG Assay 17
BioPlex 2200 - Celiac Disease IgA tTG Assay Product Status 17
BioPlex 2200 - Celiac Disease IgA tTG Assay Product Description 17
BioPlex 2200 - Celiac Disease IgA tTG Assay Product Patent Details 17
BioPlex 2200 - Celiac Disease IgG tTG Assay 19
BioPlex 2200 - Celiac Disease IgG tTG Assay Product Status 19
BioPlex 2200 - Celiac Disease IgG tTG Assay Product Description 19
BioPlex 2200 - Celiac Disease IgG tTG Assay Product Patent Details 19
BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay 21
BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay Product Status 21
BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay Product Description 21
BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay Product Patent Details 21
BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay 23
BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay Product Status 23
BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay Product Description 23
BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay Product Patent Details 23
BioPlex 2200 - Diabetes 25
BioPlex 2200 - Diabetes Product Status 25
BioPlex 2200 - Diabetes Product Description 25
BioPlex 2200 - Gastrointestinal Disease Test 26
BioPlex 2200 - Gastrointestinal Disease Test Product Status 26
BioPlex 2200 - Gastrointestinal Disease Test Product Description 26
BioPlex 2200 - Hepatitis Test 27
BioPlex 2200 - Hepatitis Test Product Status 27
BioPlex 2200 - Hepatitis Test Product Description 27
BioPlex 2200 - HIV Test 28
BioPlex 2200 - HIV Test Product Status 28
BioPlex 2200 - HIV Test Product Description 28
BioPlex 2200 - HIV/Hep Screening 29
BioPlex 2200 - HIV/Hep Screening Product Status 29
BioPlex 2200 - HIV/Hep Screening Product Description 29
BioPlex 2200 - Lyme IgG Test 30
BioPlex 2200 - Lyme IgG Test Product Status 30
BioPlex 2200 - Lyme IgG Test Product Description 30
BioPlex 2200 - Lyme IgM Assay 31
BioPlex 2200 - Lyme IgM Assay Product Status 31
BioPlex 2200 - Lyme IgM Assay Product Description 31
BioPlex 2200 - Vitamin D Test 32
BioPlex 2200 - Vitamin D Test Product Status 32
BioPlex 2200 - Vitamin D Test Product Description 32
EVOLIS - Autoimmune Panel 33
EVOLIS - Autoimmune Panel Product Status 33
EVOLIS - Autoimmune Panel Product Description 33
EVOLIS - Infectious Disease Test 34
EVOLIS - Infectious Disease Test Product Status 34
EVOLIS - Infectious Disease Test Product Description 34
Platelia Dengue NS1 Ag Microplate Assay 35
Platelia Dengue NS1 Ag Microplate Assay Product Status 35
Platelia Dengue NS1 Ag Microplate Assay Product Description 35
Bio-Rad Laboratories, Inc. - Key Competitors 36
Bio-Rad Laboratories, Inc. - Key Employees 37
Bio-Rad Laboratories, Inc. - Key Employee Biographies 38
Bio-Rad Laboratories, Inc. - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 42
Bio-Rad Laboratories, Inc., Recent Developments 42
Nov 06, 2012: Bio-Rad Reports Revenue Of $498.7m In Q3 2012 42
Aug 29, 2012: Bio-Rad Opens Digital Biology Center To Develop Products For R&D Markets Based On Its Droplet Digital Technology 42
Aug 07, 2012: Bio-Rad Reports Revenue Of $510.4m In Q2 2012 43
May 02, 2012: Bio-Rad Reports Revenue Of $486.3m In Q1 2012 43
Apr 30, 2012: Vermillion Resolves Non-Contingent Claims With Bio-Rad 44
Feb 23, 2012: Bio-Rad Reports Revenue Of $2.1 Billion In 2011 44
Nov 01, 2011: Bio-Rad Appoints Deborah J Neff To Board 45
Nov 01, 2011: Bio-Rad Reports Revenues Of $516.5m In Q3 2011 45
Aug 13, 2011: GE Healthcare And Bio-Rad Reach Settlement In Label-Free Detection Lawsuit 46
Aug 02, 2011: Bio-Rad Reports Revenue Of $521.7m In Q2 2011 46

Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Table


Bio-Rad Laboratories, Inc., Key Facts 1
Bio-Rad Laboratories, Inc. Key Pipeline Products by Equipment Type 1
Bio-Rad Laboratories, Inc. Key Pipeline Products by Therapy Area 1
Bio-Rad Laboratories, Inc. Key Pipeline Products by Development Stage 1
Bio-Rad Laboratories, Inc., Key Facts 7
Bio-Rad Laboratories, Inc., Major Products and Services 8
Bio-Rad Laboratories, Inc. Number of Pipeline Products by Equipment Type 9
Bio-Rad Laboratories, Inc. Pipeline Products by Equipment Type 10
Bio-Rad Laboratories, Inc. Number of Pipeline Products by Development Stage 11
Bio-Rad Laboratories, Inc. Pipeline Products by Development Stage 12
Bio-Rad Laboratories, Inc. Number of Pipeline Products by Therapy Area 13
Bio-Rad Laboratories, Inc. Pipeline Products by Therapy Area 14
BioPlex 2200 - Cardiac Disease - Product Status 15
BioPlex 2200 - Cardiac Disease - Product Description 15
BioPlex 2200 - Cardiac Disease - Patent Details1 15
BioPlex 2200 - Celiac Disease IgA tTG Assay - Product Status 17
BioPlex 2200 - Celiac Disease IgA tTG Assay - Product Description 17
BioPlex 2200 - Celiac Disease IgA tTG Assay - Patent Details1 17
BioPlex 2200 - Celiac Disease IgG tTG Assay - Product Status 19
BioPlex 2200 - Celiac Disease IgG tTG Assay - Product Description 19
BioPlex 2200 - Celiac Disease IgG tTG Assay - Patent Details1 19
BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay - Product Status 21
BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay - Product Description 21
BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay - Patent Details1 21
BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay - Patent Details2 22
BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay - Product Status 23
BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay - Product Description 23
BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay - Patent Details1 23
BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay - Patent Details2 24
BioPlex 2200 - Diabetes - Product Status 25
BioPlex 2200 - Diabetes - Product Description 25
BioPlex 2200 - Gastrointestinal Disease Test - Product Status 26
BioPlex 2200 - Gastrointestinal Disease Test - Product Description 26
BioPlex 2200 - Hepatitis Test - Product Status 27
BioPlex 2200 - Hepatitis Test - Product Description 27
BioPlex 2200 - HIV Test - Product Status 28
BioPlex 2200 - HIV Test - Product Description 28
BioPlex 2200 - HIV/Hep Screening - Product Status 29
BioPlex 2200 - HIV/Hep Screening - Product Description 29
BioPlex 2200 - Lyme IgG Test - Product Status 30
BioPlex 2200 - Lyme IgG Test - Product Description 30
BioPlex 2200 - Lyme IgM Assay - Product Status 31
BioPlex 2200 - Lyme IgM Assay - Product Description 31
BioPlex 2200 - Vitamin D Test - Product Status 32
BioPlex 2200 - Vitamin D Test - Product Description 32
EVOLIS - Autoimmune Panel - Product Status 33
EVOLIS - Autoimmune Panel - Product Description 33
EVOLIS - Infectious Disease Test - Product Status 34
EVOLIS - Infectious Disease Test - Product Description 34
Platelia Dengue NS1 Ag Microplate Assay - Product Status 35
Platelia Dengue NS1 Ag Microplate Assay - Product Description 35
Bio-Rad Laboratories, Inc., Key Employees 37
Bio-Rad Laboratories, Inc., Key Employee Biographies 38
Bio-Rad Laboratories, Inc., Other Locations 39
Bio-Rad Laboratories, Inc., Subsidiaries 40

List of Chart


Bio-Rad Laboratories, Inc. Pipeline Products by Equipment Type 9
Bio-Rad Laboratories, Inc. Pipeline Products by Development Stage 11
Bio-Rad Laboratories, Inc. Pipeline Products by Therapy Area 13

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *